Article

The Next HIX Challenge: Formulary, Network Comparison Tools

Left as-is, current exchange formuarly and network search technology has the potential for a lot of consumer dissatisfaction and backlash.

Left as-is, current exchange formuarly and network search technology has the potential for a lot of consumer dissatisfaction and backlash.

In just under half of the public exchanges, it is “difficult or impossible” for shoppers to figure out which drugs are covered by health plans, researchers at Avalere Health found in a study of 12 state-based and five federally-run exchanges.

In eight exchanges, plan formularies are either difficult to access, such as in Florida and New York, or almost impossible to find, with no online links to the drug lists in California, Massachusetts, Oregon, Rhode Island, Washington and Washington D.C.

In nine of the exchanges studied, formularies are at least moderately accessible, Avalere researchers found in the study, funded by Pfizer.

Read the full story here: http://bit.ly/1rObaF0

Source: Healthcare Payer News

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Hamlet Gasoyan, PhD
Constance Blunt, MD, medical oncologist, Mary Bird Perkins Cancer Center
David Awad, PharmD, BCOP
Constance Blunt, MD, medical oncologist, Mary Bird Perkins Cancer Center
Ali Khawar
Ali Khawar
Emma Achola-Kothari, PhD
Dr Emma Achola-Kothani
Dr Emma Achola-Kothari
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo